Quality of life of patients with actinic keratoses and/or a superficial basal cell carcinoma treated with 5% Imiquimod cream.
Recruiting
- Conditions
- 10040900actinic keratoses/solar keratoses and superficial basal cell carcinoma/basal cell cancer
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 500
Inclusion Criteria
Patients with actinic keratoses and/or a superficial basalcellcarcinoma, PA not neseccary
Patients are capable of treating themselve or know a person who can assist them
Patients older than 18 years
Signed informed consent
Exclusion Criteria
patients mentally or physically not capable of filling out the questionnaires/diary
Patienst who are not able to understand Dutch in a way they need to to fill out the questionnaires/diary
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The proportion of patients of which HRQOL (quality of life) increases after<br /><br>treatment, the proportion of patients satisfied with the treatment and the<br /><br>proportion of patients with therapy adherence >=80% will be described. HRQOL<br /><br>scores before and after treatment will be compared by the Mann-Whitney test.<br /><br><br /><br>Regressioncoefficients (confidence incidence)will describe which demografic and<br /><br>diseasecharacteristics are related to a change in HRQOL. With multivariable<br /><br>logistic regression we will analyze what variables are markers for (good)<br /><br>therapy adherence and treatment satisfaction ( Adjusted odds ratios and<br /><br>confidence interval).</p><br>
- Secondary Outcome Measures
Name Time Method <p>not applicable</p><br>